List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 403 studies with search of: "Bortezomib"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting A Phase 1 Dose Escalating Trial of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplasia
Condition: Myelodysplasia
Interventions: Drug: Bortezomib;   Drug: Bortezomib;   Drug: Bortezomib;   Drug: Lenalidomide
2 Recruiting Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Docetaxel, Carboplatin, Bortezomib;   Drug: Docetaxel, Carboplatin, Bortezomib
3 Active, not recruiting Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus Mitoxantrone
Condition: Prostate Cancer
Interventions: Drug: Mitoxantrone (Novantrone);   Drug: Bortezomib (PS-341)
4 Recruiting Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study
Conditions: Cancer;   Multiple Myeloma
Interventions: Drug: Bortezomib;   Drug: Bortezomib
5 Active, not recruiting Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: DOXIL/CAELYX (pegylated liposomal doxorubicin) in combination with VELCADE (bortezomib) vs. VELCADE (bortezomib)monotherapy.
6 Active, not recruiting Bortezomib (Velcade) Plus Rituximab-HyperCVAD in Patients With Mantle Cell Lymphoma
Conditions: Mantle Cell Lymphoma;   Lymphoma
Interventions: Drug: Bortezomib;   Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Vincristine;   Drug: Methotrexate;   Drug: Cytarabine;   Drug: Doxorubicin
7 Recruiting Study of Temsirolimus, Topotecan, and Bortezomib
Condition: Advanced Cancer
Interventions: Drug: Torisel (Temsirolimus);   Drug: Hycamtin (Topotecan);   Drug: Velcade (Bortezomib)
8 Recruiting Randomized Phase 3b Study in Previously Untreated Multiple Myeloma Patients: VELCADE,Thalidomide, and Dexamethasone Versus VELCADE and Dexamethasone Versus VELCADE, Melphalan, and Prednisone
Condition: Multiple Myeloma
Interventions: Drug: bortezomib, thalidomide, and dexamethasone (VTD);   Drug: bortezomib and dexamethasone (VD);   Drug: bortezomib, melphalan and prednisone (VMP)
9 Recruiting A Study of the Safety and Efficacy of CNTO 328 and Bortezomib to Bortezomib Alone in Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Biological: CNTO 328; bortezomib;   Biological: CNTO 328; placebo; bortezomib
10 Recruiting A Phase I/II Study of Liposomal Doxorubicin (Doxil)/Melphalan/Bortezomib (Velcade) in Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Liposomal Doxorubicin/Melphalan/Bortezomib
11 Active, not recruiting PS-341 Followed by Removal of Prostate for Those With Prostate Cancer
Condition: Prostate Neoplasms
Intervention: Drug: PS-341 (bortezomib)
12 Recruiting Bortezomib and Reduced Intensity Allogenic Stem Cell Transplantation for Lymphoid Malignancies
Condition: Lymphoma
Interventions: Drug: Carmustine;   Drug: Cytarabine;   Drug: Etoposide;   Drug: Melphalan;   Drug: Rituximab;   Drug: Bortezomib;   Other: Allogeneic Stem Cell Infusion
13 Recruiting Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia
Condition: Waldenstrom's Macroglobulinemia
Interventions: Drug: Bortezomib;   Drug: Rituximab
14 Recruiting Ph II Avastin + Bortezomib for Pts w Recurrent Malignant Glioma
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Avastin and Bortezomib
15 Recruiting Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma
Conditions: Melanoma;   Soft Tissue Sarcoma;   Parathyroid Carcinoma;   Small Cell Carcinoma of the Lung;   Carcinoid Tumors
Intervention: Drug: Dacarbazine and bortezomib
16 Not yet recruiting Efficacy of Bortezomib (Velcade(R)) in Patients With Advanced Waldenström Macroglobulinemia
Condition: Advanced Waldenstrom's Macroglobulinemia
Intervention: Drug: BORTEZOMIB
17 Active, not recruiting Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma
Conditions: Hodgkin Lymphoma;   Lymphoma
Interventions: Drug: Bortezomib;   Drug: Carboplatin;   Drug: Etoposide;   Drug: Ifosfamide;   Drug: Mesna
18 Active, not recruiting Bortezomib (Velcade) Post Allogenic Peripheral Blood Stem Cell Transplantation for Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Bortezomib
19 Recruiting Bevacizumab and Bortezomib in Patients With Advanced Malignancy
Conditions: Advanced Malignancy;   Lymphoma;   Myeloma;   Solid Tumors
Interventions: Drug: Bevacizumab;   Drug: Bortezomib
20 Recruiting Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors
Conditions: Solid Tumor;   Urethral Cancer
Interventions: Drug: Bortezomib;   Drug: Gemcitabine;   Drug: Doxorubicin

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services